Medical Implant Coating Composition Against Foreign Substance Adhesion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing medical implants face challenges with foreign substance adhesion, leading to infections and complications such as thrombus formation, which conventional coatings do not adequately address.
Innovation Solution
A coating composition comprising a stock solution with aliphatic hydrocarbon solvent, siloxane compound, alcohol, amino silanes, and silane-based oligomer, along with a diluted solution, effectively prevents foreign substance adhesion on implants by forming a protective layer.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If conventional coatings are applied to medical implants, then the implant surface is covered, but foreign substance adhesion (blood, bacteria, mucus) still occurs leading to infections and thrombus formation
Solution Approach 1:
The patent employs a composite coating system comprising multiple components: a base coating layer and a silane-based oligomer layer. This multi-layer composite structure combines different materials with complementary properties to achieve superior anti-fouling performance that prevents adhesion of blood, bacteria, and mucus while maintaining implant reliability
Solution Approach 2:
The patent modifies surface energy parameters by applying a silane-based oligomer coating that changes the surface chemistry and physical properties. This parameter change creates a surface with specific energy characteristics that actively repel foreign substances, transforming the surface from adhesive to non-adhesive for biological materials
2Object-affected harmful factors
If the coating composition includes multiple components (stock solution and diluted solution), then the anti-fouling performance is enhanced, but the manufacturing process becomes more complex
Solution Approach 1:
The coating composition is divided into two distinct segments: a stock solution containing the base coating components and a diluted solution containing the silane-based oligomer. This segmentation allows each component to be optimized independently and applied in a controlled sequence, enhancing anti-bacterial performance while managing manufacturing complexity through modular preparation
3Object-affected harmful factors
If a protective coating layer is formed on the implant, then foreign substance adhesion is reduced, but the coating application process requires precise control
Solution Approach 1:
The patent applies the silane-based oligomer coating as a preliminary action before final implant deployment. This preliminary coating step establishes the anti-fouling surface properties in advance, ensuring that when the implant is introduced to biological environments, the protective layer is already in place to prevent mucus and other substance adhesion, reducing the need for precise real-time control during application
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The coating composition significantly reduces the adhesion of substances like blood, mucus, and bacteria, thereby minimizing infections and thrombus formation, enhancing surgical safety and precision.
Implementation Method 1
a coating composition comprising a stock solution and a diluted solution, in which the stock solution includes an aliphatic hydrocarbon solvent; a siloxane compound; an alcohol; one or more amino silanes; and a silane-based oligomer
Data Source
AI summary
Provided is a coating composition for a medical implantable device to prevent foreign substance adhesion, and more specifically, the coating composition includes a stock solution and a diluted solution, and the stock solution includes an aliphatic hydrocarbon solvent; a siloxane compound; an alcohol; one or more amino silanes; and a silane-based oligomer.